Medicine guide

GAZYVARO

As listed in the register: GAZYVARO 1000 mg, solution à diluer pour perfusion

1000 mg · solution à diluer pour perfusion

  • Prescription only
Active substance
Obinutuzumab
Made by
ROCHE REGISTRATION (ALLEMAGNE)

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

United StatesNo exact match for this strength and form

European UnionNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

Details

Made byROCHE REGISTRATION (ALLEMAGNE)
Active substanceObinutuzumab
Strength1000 mg
Formsolution à diluer pour perfusion
Routeintraveineuse
Dispensing (as stated by the register)réservé à l'usage HOSPITALIER · médicament nécessitant une surveillance particulière pendant le traitement · prescription réservée aux spécialistes et services MEDECINE INTERNE · prescription réservée aux spécialistes et services HEMATOLOGIE · prescription réservée aux spécialistes et services NEPHROLOGIE · prescription réservée aux spécialistes et services RHUMATOLOGIE · liste I · prescription réservée aux médecins compétents en maladie du sang
MarketedYes, according to the register
Authorisation procedureProcédure centralisée
EU numberEU/1/14/937
Name in the registerGAZYVARO 1000 mg, solution à diluer pour perfusion
Packs1 flacon(s) en verre de 40 ml
CIS61042996
CIP133400958700361

Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician

Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).